EGF and neoplasm: However, encapsulation of DOX in nanoparticles and EGF modification significantly decreased the accumulation of the drug in the cardiac tissues and increased its content in the tumor tissues (0.11 ± 0.07 μg/mL of free DOX vs 0.32 ± 0.10 μg/mL of EGF@DOX-NPs).